Sutro Biopharma, Inc. (BOATS:STRO) Financings
Financings
| Raise | Date |
|---|---|
| Public offering of common stock Announced: about US$110M · US$13.98 a share · Leerink Partners +2 Dealers: Leerink Partners (co-lead), TD Cowen (co-lead), LifeSci Capital (co-lead) Buyers: BVF Partners L.P.; Samsara BioCapital; Coastlands Capital; Eventide Asset Management; Perceptive Advisors; RA Capital Management; ADAR1 Capital Management; Affinity Asset Advisors; Acuta Capital Partners Use of proceeds: General corporate purposes, including research, clinical and process development and manufacturing of product candidates, and working capital | Feb 10, 2026 |